Cuba vs Ghana: Treatment success rate for patients treated for MDR-TB
Cuba
67.0%
in 2022
Ghana
67.0%
in 2022
Cuba rank
106th
Ghana rank
106th
Treatment success rate for patients treated for MDR-TB over time
- Cuba
- Ghana
How they compare
Cuba currently reports 67.0% against 67.0% in Ghana, a difference of 0.0%.
The two have swapped places 6 times across 13 shared years of data; in 2010 it was Ghana ahead.
Cuba ranks 106th and Ghana ranks 106th of 163 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cuba | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.7% | 62.3% | 5.6% | Ghana |
| 2020s | 58.0% | 71.7% | 13.7% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cuba or Ghana?
- Cuba, at 67.0% against 67.0% in Ghana as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cuba and Ghana?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Ghana?
- 13 years are reported by both, from 2010 to 2022.
- How do Cuba and Ghana rank globally for treatment success rate for patients treated for mdr-tb?
- Cuba ranks 106th and Ghana ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.